Mary Dixon
- Pharmacology top 5%
- Rheumatology top 10%
- Cardiology and Cardiovascular Medicine
- Pharmacology top 10%
- Surgery
- Co-authors
- Adam B. PolisGregory P. Gebafor the Mexican Nephrology Collaborative Study GroupArthur L. WeaverThomas J. SchnitzerJeffrey LisseGunnar JohanssonJoy Schechtman
- Topics
- Inflammatory mediators and NSAID effects (3 papers)Neuropeptides and Animal Physiology (2 papers)Synthesis of β-Lactam Compounds (2 papers)
- Cited by
- PharmacologyRheumatology
- Partner nations
- United StatesSwedenJapan
In The Last Decade
Mary Dixon
4 papers receiving 303 citations
Peers
Comparison fields: 5 of 65
- Pharmacology 253
- Rheumatology 113
- Cardiology and Cardiovascular Medicine 67
- Pharmacology 54
- Surgery 45
Countries citing papers authored by Mary Dixon
This map shows the geographic impact of Mary Dixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Dixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Dixon more than expected).
Fields of papers citing papers by Mary Dixon
This network shows the impact of papers produced by Mary Dixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Dixon. The network helps show where Mary Dixon may publish in the future.
Co-authorship network of co-authors of Mary Dixon
This figure shows the co-authorship network connecting the top 25 collaborators of Mary Dixon. A scholar is included among the top collaborators of Mary Dixon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Dixon. Mary Dixon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 102 | |
| 3 | 187 | |
| 4 | 11 |
About Mary Dixon
Mary Dixon is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Organic Chemistry, having authored 4 papers that have together received 327 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (3 papers), Neuropeptides and Animal Physiology (2 papers) and Synthesis of β-Lactam Compounds (2 papers). The work is most often cited by research in Pharmacology (253 citations), Rheumatology (113 citations) and Pharmacology (54 citations). Mary Dixon has collaborated with scholars based in United States, Sweden and Japan. Frequent co-authors include Adam B. Polis, Gregory P. Geba, for the Mexican Nephrology Collaborative Study Group, Arthur L. Weaver, Thomas J. Schnitzer, Jeffrey Lisse, Gunnar Johansson, Joy Schechtman, Herbert S. B. Baraf and Richard A. Petruschke. Their work appears in journals such as JAMA, Annals of Internal Medicine and Journal of the American Geriatrics Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.